Using real-time (Taqman) RT-PCR to measure gene expression- a core facility of the UK . (2004)

Smith, R. L., Painter, H., Gill, D. R. & Hyde, S. C.

Journal of Cystic Fibrosis, 3, S5

Download   Back

Gene therapy for cystic fibrosis has been predominantly aimed at correcting the chloride ion transport defects in the lung epithelia. Mouse and sheep lung models are widely used to assess the effectiveness of a variety of gene transfer vectors and to test delivery methods to be used in the clinic (e.g. bronchoscopy, aerosolization, etc.). Testing in these animal models requires a sensitive, fast and accurate way of measuring gene transfer. Routine protein expression studies using reporter genes have proved of limited use due to the sensitivity required to detect low levels of expression that may still be therapeutic. At the John Radcliffe Hospital in Oxford, we have established a Core Testing Service using the ABI7700 Sequence Detector (TaqmanÆ) to quantify vector delivery (DNA) and gene expression (mRNA). Measurement of gene transfer using the reverse transcriptase polymerase chain reaction (RT-PCR) in real time with the TaqmanÆ can be performed in a range of pre-clinical and patient samples including blood, tissue biopsies, airway brushings and bronchial washings. Samples are collected in RNAlaterÆ stabilization solution (Ambion), transported to the core facility and the RNA extracted using the RNEasyÆ mini kit (Qiagen). A reverse transcriptase step is performed, and the resultant cDNA amplified using the TaqmanÆ instrument. An endogenous gene is analyzed simultaneously and the quantitative result normalized to the endogenous expression level. The sensitivity of the assay is 102 target RNA molecules in ???ng of RNA, with intra-assay variability typically less than 2%. RT-PCR in real time is a reliable and sensitive method to assess gene transfer efficiency and is recommended as an end-point assay for clinical assessment of gene transfe

Home
News
Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Careers
Resources
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images

 

UK CFGTC

How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

Milestones

GL67A/pGM169

The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial

 

Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links

 

Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links

 

 

Publications

Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses

Lectures

 

Gene Therapy Seminars

Schedule

Directions & Venue